Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study

被引:7
|
作者
McKay, Kyla A. [1 ,2 ]
Wickstrom, Ronny [3 ]
Hillert, Jan [1 ]
Karrenbauer, Virginija Danylaite [1 ,4 ]
机构
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[2] Karolinska Univ Hosp, Ctr Mol Med CMM L8 05, S-17176 Stockholm, Sweden
[3] Karolinska Univ Hosp, Astrid Lindgrens Childrenss Hosp, Neuropediat Unit, Stockholm, Sweden
[4] Karolinska Univ Hosp, Theme Neuro, Stockholm, Sweden
基金
瑞典研究理事会; 加拿大健康研究院;
关键词
DIAGNOSTIC-CRITERIA; CHILDREN; MS;
D O I
10.1038/s41598-021-97543-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
To investigate whether cerebrospinal fluid (CSF) markers differ between pediatric-onset multiple sclerosis (PoMS, onset < 18 years) and adult-onset (AoMS), and whether these markers are associated with clinical outcomes among PoMS. Prospective nationwide registry study of incident MS, including persons with a CSF sample < 3 years post-MS onset. We compared CSF oligoclonal band (OCB) status, immunoglobulin G (IgG) index levels, and mononuclear cell count between PoMS and AoMS. Within the PoMS cohort we analyzed the association between CSF markers, relapse rate and Expanded Disability Status Scale (EDSS) score, using negative binomial regression and generalized estimating equations, respectively. The cohort consisted of 130 PoMS and 3228 AoMS cases. The PoMS group had higher odds of OCB-positivity (odds ratio: 2.70; 95% CI 1.21-7.67). None of the CSF markers were associated with relapse rate in the PoMS cohort; however, OCB-positivity was associated with higher EDSS scores. This study suggested that PoMS more commonly display CSF evidence for intrathecal IgG production than AoMS. Further, we found evidence of a relationship between OCB-positivity and subsequent disability, suggesting that they could play a role in the prognostication of MS in children.
引用
收藏
页数:6
相关论文
共 50 条
  • [11] The use of natalizumab in pediatric-onset multiple sclerosis
    Alroughani, Raed
    Akhtar, Saeed
    Ahmed, Samar
    Al-Hashel, Jasem
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP7 - NP8
  • [12] Rituximab treatment in pediatric-onset multiple sclerosis
    Breu, Markus
    Sandesjo, Fredrik
    Milos, Ruxandra-Iulia
    Svoboda, Jan
    Salzer, Jonatan
    Schneider, Lisa
    Reichelt, Julian Benedikt
    Bertolini, Annikki
    Blaschek, Astrid
    Fink, Katharina
    Hoeftberger, Romana
    Lycke, Jan
    Rostasy, Kevin
    Seidl, Rainer
    Siegert, Sandy
    Wickstrom, Ronny
    Kornek, Barbara
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (05)
  • [13] Validation of the Swedish Multiple Sclerosis registry for pediatric-onset multiple sclerosis
    Sandesjo, Fredrik
    Alping, Peter
    Fink, Katharina
    Wickstrom, Ronny
    Piehl, Fredrik
    Frisell, Thomas
    Mckay, Kyla A.
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2025, 11 (01)
  • [14] Neurodegeneration and humoral response proteins in cerebrospinal fluid associate with pediatric-onset multiple sclerosis and not monophasic demyelinating syndromes in childhood
    Bruijstens, Arlette L.
    Stingl, Christoph
    Stoop, Marcel P.
    Wong, Yu Yi M.
    van Pelt, E. Danielle
    Banwell, Brenda L.
    Bar-Or, Amit
    Luider, Theo M.
    Neuteboom, Rinze F.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (01) : 52 - 62
  • [15] Rates of Depression and Suicidality in Pediatric-Onset Multiple Sclerosis: A Pilot Study
    Sobejano, Isabella
    Stoney, Sarah
    Kunzelman, Elizabeth
    Black, Chelsea
    Waldman, Amy
    Hopkins, Sarah
    Narula, Sona
    Banwell, Brenda
    NEUROLOGY, 2023, 100 (17)
  • [16] TyPed study: Natalizumab for the treatment of pediatric-onset multiple sclerosis in Portugal
    Palavra, Filipe
    Figueiroa, Sonia
    Correia, Ana Sofia
    Tapadinhas, Fernando
    Cerqueira, Joao
    Guerreiro, Rui Pedro
    de Sa, Joao
    Sa, Maria Jose
    Almeida, Sofia
    Mota, Patricia
    Sousa, Livia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 51
  • [17] Long-term socioeconomic outcomes associated with pediatric-onset multiple sclerosis: A nationwide prospective cohort study
    McKay, Kyla
    Friberg, Emilie
    Razaz, Neda
    Alexanderson, Kristina
    Hillert, Jan
    NEUROLOGY, 2021, 96 (15)
  • [18] MRI findings in pediatric-onset multiple sclerosis patients: A retrospective study
    Berger, Annika
    Healy, Brian C.
    Egorova, Svetlana
    Duan, Yang
    Khoury, Samia
    Weiner, Howard
    Chitnis, Tanuja
    Guttmann, Charles
    NEUROLOGY, 2008, 70 (11) : A134 - A134
  • [19] Cognitive and Psychological Functioning in Pediatric-Onset Multiple Sclerosis
    Putnam, Mary C.
    Braaten, Ellen B.
    O'Donnell, Ellen H.
    Gorman, Mark P.
    Chitnis, Tanuja
    NEUROLOGY, 2009, 72 (11) : A370 - A370
  • [20] Social cognition in pediatric-onset multiple sclerosis (MS)
    Charvet, L. E.
    Cleary, R. E.
    Vazquez, K.
    Belman, A. L.
    Krupp, L. B.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (11) : 1478 - 1484